ixazomib plus lenalidomide
TakedaThe drug was developed by Takeda. In the US, it is approved since November 2015, and in the EU since November 2016. Ixazomib is used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adults after at least one prior - ?...
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
ixazomib plus lenalidomide
Industry
N/A
Technology
N/A
Location
Ixazomib, US
Founded
N/A
Employees
N/A
Category
Investors
Contact Information
Email
N/A
Phone
N/A
Address
N/A